WHO approved India Biotech’s Covaxin for Emergency Use List (ELU) – SarkariFlix

The World Health Organization (WHO) has approved the Covaxin vaccine, developed by domestic pharma company India Biotech, to fight the corona epidemic. The WHO has approved the inclusion of this vaccine in the Emergency Use List (EUL).

The WHO tweeted this on Wednesday. This recognition will enable the vaccine to be distributed to countries around the world. There are no restrictions or self-imposed restrictions on foreigners who have been vaccinated.

India Biotech first informed the World Health Organization on April 19 for inclusion in the Emergency Consumer List. The Committee of Experts has met several times on this. The WHO Technical Advisory Team reviewed the data on the clinical trials of Kovaggin vaccine, safety, efficacy, and immunisation.

RELATED  H5N8: Russia said that the first case of H5N8 avian flu has been detected in humans

Then allowed to join the EUL. It is already known that covagin vaccine is being used in India. The vaccine, which is taken in two doses, protects against the corona as well as several variants.

Biotech India has been taking the initiative to control the corona epidemic since before the vaccine was developed. The antidote to this virus, which has become a major challenge to the world, is intended to be made in India rather than imported. Kovaggin was developed by rapidly conducting tests without compromising on standards.

RELATED  Covid-19 News World: Britain's economy, retail sales growing rapidly, recovering from Corona

Having a BSL-3 lab facility, Kovacgin was created with the experience of making vaccines for many pandemics in the past. Kovaggin, which is widely used in our country, provides 77.8 per cent protection against the corona virus, while 65.2 per cent protection from the delta variant.

RELATED  Ma Rainey's Black Bottom Won two awards at BAFTA award 2021
WHO approved India Biotech’s Covaxin
WHO approved India Biotech’s Covaxin
Share

Leave a Comment

Your email address will not be published.